Neural hyperactivation in carriers of the Alzheimer's risk variant on the clusterin gene (Q24296703)

GOA release 2020-03-11

author

Stephen J Johnston

5

0 references

Thomas M. Lancaster

1

0 references

Margaret C. Jackson

4

0 references

Rossen Donev

6

0 references

Johannes Thome

7

object named as

Johannes Thome

0 references

author name string

Alison Baird

2

0 references

Claudia Wolf

3

0 references

David E J Linden

European Neuropsychopharmacology

8

0 references

language of work or name

English

0 references

publication date

December 2011

0 references

published in

0 references

volume

21

0 references

issue

12

0 references

page(s)

880-4

0 references

cites work

Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2011.02.001

7 January 2021

Genetic variation and neuroimaging measures in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2011.02.001

7 January 2021

Replication of CLU, CR1, and PICALM associations with alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2011.02.001

7 January 2021

Automated Talairach Atlas labels for functional brain mapping

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2011.02.001

7 January 2021

Evolution of neuronal changes in the course of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2011.02.001

7 January 2021

Imaging genetics of cognitive functions: Focus on episodic memory

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2011.02.001

7 January 2021

Increased functional brain response during word retrieval in cognitively intact older adults at genetic risk for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2011.02.001

7 January 2021

Interactive effects of physical activity and APOE-ε4 on BOLD semantic memory activation in healthy elders

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2011.02.001

7 January 2021

Mechanism of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP3 receptor channel gating.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2011.02.001

7 January 2021

Presenilin-mediated signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2011.02.001

7 January 2021

Functional activation imaging in aging and dementia

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2011.02.001

7 January 2021

Are faces special in Alzheimer's disease? Cognitive conceptualisation, neural correlates, and diagnostic relevance of impaired memory for faces and names

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2011.02.001

7 January 2021

Enhanced visual short-term memory for angry faces.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2011.02.001

7 January 2021

Dysbindin-1 genotype effects on emotional working memory

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2011.02.001

7 January 2021

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2011.02.001

7 January 2021

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2011.02.001

7 January 2021

Alzheimer disease: New light on an old CLU.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2011.02.001

7 January 2021

Patterns of brain activation in people at risk for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2011.02.001

7 January 2021

Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2011.02.001

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2011.02.001

1 reference

7 January 2021

Genome-wide association studies in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2011.02.001

7 January 2021

Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2011.02.001

7 January 2021

Neuronal death in Alzheimer's disease and therapeutic opportunities.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2011.02.001

7 January 2021

APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2011.02.001

7 January 2021

Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2011.02.001

7 January 2021

Increased Brain Activation During Working Memory in Cognitively Intact Adults With the APOE ε4 Allele

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2011.02.001

7 January 2021

fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2011.02.001

7 January 2021

Semantic memory activation in individuals at risk for developing Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURONEURO.2011.02.001

7 January 2021

10.1016/J.EURONEURO.2011.02.001

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

4252723

4252723

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference